Parent Interventions: Navigating through the Pandemic  |  Health Monitor: Attention and Memory Deficits in People Who Experienced Mild Covid  |  Parent Interventions: How can we Revert Peanut Allergies in Children?  |  Teacher Insights: Play Based Learning has a Positive Impact on Child's Learning and Development  |  Health Monitor: Social Media Use Likely to Affect the Physical Health of a Person  |  Parent Interventions: How to Deal with Developmental Language Disorder in Children  |  Health Monitor: Lifestyle Interventions from Early Childhood Prevents Cardiovascular Diseases  |  Teacher Insights: Teacher Expectations Can Have Powerful Impact on Students Academic Achievement  |  Policy Indications: Make Sure the Digital Technology Works for Public Good  |  Teacher Insights: The Significance of Social Emotional Learning Curriculum in Schools  |  Health Monitor: Forgetting is a Form of Learning  |  Higher Studies: University of Manchester Invites Application for LLB and LLM Programmes   |  Health Monitor: Is There a Blue Spot Inside our Brain?  |  Parent Interventions: Babies born during the Pandemic Performs Lower during Developmental Screening  |  Policy Indications: Invest in Structural Steel R&D : Prof BS Murty  |  
April 23, 2020 Thursday 03:57:35 PM IST

First Artificial Pancreas App

International Edu News

The University of Cambridge has developed the world's first downloadable artificial pancreas app for people with type 1 diabetes. The CamAPS FX app works with an insulin pump and a glucose monitor to automatically deliver insulin to people living with the condition via a complex algorithm. The app was developed based on over a decade of research by Professor Roman Hovorka.It will be useful in patients who experience potentially dangerous low blood glucose levels at night. The app can also upload the user’s blood glucose measurements seamlessly to Diasend, an online platform, allowing their diabetes team to provide more personalised care.The app is now available for UK users to download onto Android phones via the Amazon Appstore. The app is available on a subscription basis starting at £70 per month.It is licensed for use by both adults and children with the condition and is the first artificial pancreas system to be licensed for use in pregnancy, or by young children aged one and above.

Comments